1. Sankyo Co., Ltd. (1991). Development of pravastatin for treatment of hyperlipidemia (in Japanese) (pp. 8–17). Special Prize for Okochi Memorial Production.
2. Brown, M. S., & Goldstein, J. L. (1981). Lowering plasma cholesterol by raising LDL receptors. New England Journal of Medicine, 305, 515–517.
3. CS-514 Study Group. (1988a). Clinical efficacy of CS-514 (Pravastatin) for hyperlipidemia–multiclinic open study results-. Clinician Pharmaceuticals, 4(3), 409–437.
4. CS-514 Study Group. (1988b). Examination of the clinical usefulness of long-term administration of CS-514 (Pravastatin) for hyperlipidemia. Clinician Pharmaceuticals, 4(2), 201–227.
5. Editorial Board of Sankyo 100 Years. (2002). Sankyo 100 years. Sankyo Co., Ltd.